Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The trial will evaluate the extended bactericidal activity of 14 consecutive days of oral administration of PA-824 at 50, 100, 150 and 200 mg per day in adult patients with newly diagnosed, uncomplicated, smear positive tuberculosis (TB). A control group will receive standard TB treatment.
Critère d'inclusion
- Pulmonary tuberculosis